Evidence map›Paper›PMID 41596779›Full record

ArticleInternational journal of molecular sciences2026

Correction: Nosi et al. MET Exon 14 Skipping: A Case Study for the Detection of Genetic Variants in Cancer Driver Genes by Deep Learning.

Vladimir Nosi, Alessandrì Luca, Melissa Milan, Maddalena Arigoni, Silvia Benvenuti, Davide Cacchiarelli, Marcella Cesana, Sara Riccardo, Lucio Di Filippo, Francesca Cordero and 3 more

Abstract readPublished Erratum
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Vladimir NosiDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Alessandrì LucaDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Melissa MilanCandiolo Cancer Institute-FPO, IRCCS, 10060 Candiolo, Italy.
Maddalena ArigoniDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Silvia BenvenutiCandiolo Cancer Institute-FPO, IRCCS, 10060 Candiolo, Italy.
Davide CacchiarelliTelethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.
Marcella CesanaTelethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.
Sara RiccardoTelethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.
Lucio Di FilippoTelethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.
Francesca CorderoDepartment of Computer Sciences, University of Torino, 10149 Torino, Italy.ORCID 0000-0002-3143-3330
Marco BeccutiDepartment of Computer Sciences, University of Torino, 10149 Torino, Italy.
Paolo M ComoglioIFOM-FIRC Institute of Molecular Oncology, 20139 Milano, Italy.ORCID 0000-0003-4971-3987
Raffaele A CalogeroDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0002-2848-628X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The journal's Editorial Office and Editorial Board are jointly issuing a resolution and removal of the Journal Notice linked to this article [...].

Identifiers

PMID41596779
PMCPMC12842482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.